MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: BioPharmaceuticals _ Orphan & Rare Diseases
Amryt Pharma Plc (NASDAQ: AMYT)
Organization & Developments: Amryt Pharma
Parents
Amryt Pharma Plc (NASDAQ: AMYT)
Children
2022: FDA has granted Orphan Drug Designation to Mycapssa for the treatment of carcinoid syndrome
Jumps
Finance & Acquisitions: Amryt Pharma
Key People: Amryt Pharma